VITAMINE D3 2000 UI
Food supplement declared in France, declaration No 2020-11-1210
VITAMINE D3 2000 UI (ORFITO) is a food supplement declared in France. Status: retrait du marché annoncé pour le 17 July 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked. Its name nevertheless states a dose above the maximum set in France in 2006: see the composition.
- Brand
- ORFITO
- Food business operator placing the product on the market
- BioUltime
- Status
- Retrait du marché annoncé pour le 17 July 2027
- Form
- Comprimé
- Daily dose
- 1 comprimé
- Directions for use
- 1 comprimé par jour à avaler avec un grand verre d'eau
- Not recommended for (according to the manufacturer)
- Enfants (moins de 12 ans)
Declaration 171420, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 17 July 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
The product name states 50 µg of vitamine D per serving, above the maximum dose of 5 µg set by the Order of 9 May 2006, not revised since November 2006. Check the dose and number of servings on the label. The EFSA The limite de sécurité for adults, including food, is 100 µg per day.
Additives
E420, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : ORFITO